🇬🇧 Gynecological Cancers in 2025: New Strategies and Advances in Chemotherapy скачать в хорошем качестве

🇬🇧 Gynecological Cancers in 2025: New Strategies and Advances in Chemotherapy

Debate on Current Cancer Treatments, recorded as part of the Chemotherapy Course 2025 at Gustave Roussy. This video has been dubbed in English using AI. This debate has been translated and dubbed into English by artificial intelligence. First topic on ovarian cancer: After the negative results of PRIMA, who should be offered a PARP inhibitor as first-line treatment? Second topic on locally advanced cervical cancer: Induction chemotherapy or radio-chemotherapy (with or without immunotherapy)? 00:00 Introduction 01:22 Ovarian cancers: The limitations of the PRIMA study 04:10 PRIMA vs PAOLA comparison: Differences and implications 06:04 Relapse on PARP inhibitor: What impact? 07:22 What future for maintenance therapy in first-line? 08:34 Cervical cancers: Two recent trials under study 10:36 Induction chemotherapy: Benefits and limitations 12:50 Radio-chemotherapy + immunotherapy: What interest? 15:02 Strategies based on stages: Towards personalized care ——Links—— Gustave Roussy website for the courses https://www.coursdechimio.com/home/ All other debates in English: Breast cancer in 2025: Radiotherapy, surgery, mutations, how research is redefinning local treatments:    • 🇬🇧 Breast cancer in 2025: research redefin...   Pancreatic Cancer in 2025 Challenges, Therapeutic Advances, and Future Perspectives:    • 🇬🇧 Pancreatic Cancer in 2025 Challenges, T...   -Prostate cancer Will PARP inhibitors change everything in 2025 ?:    • 🇬🇧 Prostate cancer: Will PARP inhibitors c...   -Bronchial cancers in 2025 New strategies for stage III:    • 🇬🇧 Bronchial cancers in 2025: New strategi...   #OvarianCancer #PARPInhibitors #GynecologicalCancerChemotherapy#CervicalCancer #GynecologicalOncology #GustaveRoussy